Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

The Lancet

Volumn 343, Issue 8902, 1994, Pages 886-889

  Levine, M ^a,b   Hirsh, J ^a   Arnold, A ^a,b   Gent, M ^a   Bramwell, V ^c   Pritchard, K I ^d   Stewart, D ^e   Warr, D ^f   Goodwin, P ^g   Samosh, M ^h   Falanga, A ⁱ  

^a MCMASTER UNIVERSITY   (Canada)

^b Clinical Epidemiology and Biostatistics McMaster University ^*  (United Kingdom)

^c London Regional Cancer Centre   (Canada)

^d Regional Cancer Centre London United Kingdon ^*  (United States)

^e OTTAWA REGIONAL CANCER CENTRE   (Canada)

^f Princess Margaret Hospital   (United Kingdom)

^g MOUNT SINAI HOSPITAL   (Canada)

^h Hotel Dieu Hospital   (Canada)

ⁱ Hotel Dieu Hospital ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PLACEBO; VITAMIN K GROUP; WARFARIN;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM;

EID: 0028296769     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)90008-6     Document Type: Article

References (27)

1. Activation of blood coagulation in cancer: Trousseau's syndrome revisited
2. The thrombogenic effect of anti-cancer drug therapy in women with stage II breast cancer
3. Venous thrombosis during multimodal treatment of primary breast carcinoma
4. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer
5. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five drug chemotherapy regimen
6. Prevention of venous thromboembolism
7. Oral anticogulants mechanism of action clinical effectiveness and optimal therapeutic range
8. Canadian atrial fibrillation anticoagulation study
9. Different intensities of oral anticoagulant therapy in the treatment of proximal vein thrombosis
10. Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement
11. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves
12. Very low doses of warfarin can prevent thrombosis in central vein catheters: a randomized prospective trial
13. Fixed mini-dose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery
14. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation
15. Detection of deep vein thrombosis by real-time B-mode ultrasonography
16. Impedance plethysmography using the occlusive cuff technique in the diagnosis of venous thrombosis
17. Roentgen diagnosis of venous thrombosis in the leg
18. Pulmonary angiography, ventilation lung scanning and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan
19. Prevention of deep vein thrombosis after elective hip surgery: a randomised trial comparing low molecular weight heparin with standard unfractionated heparin
20. Non-parametric estimation of incomplete observations
21. Evaluation of survival data and two new rank order statistics arising in its consideration
22. The diagnosis and treatment of thrombosis in the cancer patient
23. Efficacy of fixed mini-dose warfarin prophylaxis in total hip replacement
24. Prevention of venous thrombosis with mini-dose warfarin after joint replacement
25. Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation
26. Basis for selection of anticoagulant drugs for therapeutic trials in human malignancy
27. Effect of warfarin on survival in small cell carcinoma of the lung